CD40LG and atherosclerosis: In animal models, anti-oxLDL antibody (Fab or Fv fragment) infusion and immunization of MDA- or MAA-modified LDL, which leads to high levels of serum antibodies (IgM and possibly IgG1), have both been shown to confer protection against atherosclerosis [4, 33, 34].